Udemy Inc (UDMY – Research Report) received a Hold rating and price target from William Blair analyst Stephen Sheldon yesterday. The ...

Fintel reports that on March 12, 2025, William Blair downgraded their outlook for Udemy (NasdaqGS:UDMY) from Outperform to ...

William Blair downgraded shares of Udemy (NASDAQ:UDMY – Free Report) from an outperform rating to a market perform rating in ...

William Blair downgraded Udemy (UDMY) to Market Perform from Outperform after the company announced the appointment of Hugo Sarrazin as ...

(Bloomberg) -- JPMorgan Chase & Co. has hired William Kallop from William Blair & Co. for its mergers and acquisitions group focused on private equity firms and sovereign wealth funds. Kallop is ...

Investing.com -- William Blair upgraded Palantir Technologies (NASDAQ:PLTR) to Market Perform following a 33% selloff from $125 to $84 over the past three weeks, despite concerns over its valuation.

Investing.com -- William Blair upgraded Palantir Technologies (NASDAQ:PLTR) to Market Perform following a 33% selloff from $125 to $84 over the past three weeks, despite concerns over its valuation.

William Blair currently has a “Neutral” rating and a $14.00 price target on the stock. The consensus estimate for Intellia Therapeutics’ current full-year earnings is ($5.07) per share. Get ...

Palantir (NASDAQ:PLTR) was upgraded to Market Perform from Underperform by William Blair, following the recent share price decline by the data analysis and artificial intelligence software firm.

Autism care software maker CentralReach has been exploring a sale, Business Insider has learned. CentralReach has tapped the investment bank William Blair to pursue a potential sale, according to ...